SWIM vs TRNS

SWIM exhibits stable financial health with a Piotroski F-Score of 6/9, though it lacks an Altman Z-Score for bankruptcy risk assessment. The stock is significantly overvalued relative to its Graham Number ($2.65) and Intrinsic Value ($0.63), trading at a steep premium based on growth expectations. While revenue growth is consistent at 14.5%, the company struggles with negative operating margins (-10.73%) and highly volatile earnings. Analyst sentiment remains bullish with a target of $8.50, creating a sharp divergence between deterministic value metrics and market expectations.

Transcat exhibits strong operational health with a Piotroski F-Score of 8/9 and a conservative debt profile, yet it is fundamentally decoupled from its valuation. While revenue growth remains robust at 25.6%, the company is suffering a severe earnings collapse with YoY EPS growth down 42.2% and a razor-thin profit margin of 2.47%. The current price of $81.76 represents a massive premium over the Graham Number ($24.66) and Intrinsic Value ($5.95), suggesting the market is pricing in growth that is not currently manifesting in the bottom line.